Newsroom
Spotlight Story
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Read more
Press Releases
UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and…
Read More
UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control…
Read More
UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330…
Read More
BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in…
Read More
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly…
Read More
UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
Read MoreUCB Stories
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association…
Read More
Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated…
Read More
3 in 3: Advancing hope for rare and ultra-rare disease communities, one innovation at a time
Read More
Innovation Equals Access: How UCB Delivered for Patients in 2025
Read More
More than Medicine: UCB's Holistic Approach to Supporting MG Patients
Read More
